|
Re: Pertuzumab: Today's The Day
The insurance will be the key. Pertuzumab like all brand new drugs are, will be highly priced so Roche can recoup their investment. Insurance co's are not in business to help patients--they want to make money so I'm betting they will closely scrutinize claims for Pert. in effect, unintentionally policing for the FDA.
If the FDA had approved this 2yrs ago when it was reviewed, which was before my dx, I and others would have benefitted. But they didn't, so basically they have decided our lives are not worth it---not then, not now.
I'm very, very letdown about this but I see my onc Monday and will discuss if Pert. will be an option for me if God forbid, my mets do not respond to Abraxane.
__________________
Vicki
Lord, give me the comfort of Your embrace and acceptance of Your will.
3/11: DX: IDC, HER2++, ER/PR neg, stage 4, mets to liver. Primary tumor: grade 3; 11 cm. 2nd smaller tumor: ~2.5cm. Multiple affected nodes, 1 spot on liver. 6 rounds TCH prior to bmx.
7/11: Nothing left except Primary breast tumor now 1.5cm.
8/11: BMX, 17/17 nodes clear. No post-op chemo or radiation indicated. NED!
10/11: NED! Continue Herceptin indef.
2/12: Reoccurence of liver mets; both lobes. Tykerb added to Herceptin.
5/12: Progression of liver mets. Stop Tykerb, start Abraxane & Herceptin weekly.
8/12: Progression in liver and lymph nodes around liver and right kidney. Herceptin not working anymore! Stop Abraxane and Herceptin. Start Tykerb and Xeloda.
10/12: Severe side effects. 3 weeks break from everything.
12/12: It's working! All tumors gone except 2 (from 20+) Continue Tykerb and Xeloda. Brain and spine MRIs clear.
|
Hybrid Mode
